The device is programmed to recognize a target on a cell surface; its drug payload secured within anchor strands of DNA.

Nano Vivere (ISIN: CN0024013913), a late stage clinical company, pioneering nanomedicine whose technology is based on proprietary technologies and patents, today announced that scientists, have developed a drug-delivering nanorobot that looks like an open-ended barrel.
The exterior surface of the device is programmed to recognize a target on a cel..

View more at https://www.1888pressrelease.com/nanorobot-as-molecular-scale-a-nano-vivere-study-pr-639968.html